Brett Schulman, Cava CEO, joined Cheddar News to talk about his company going public. "We think the market is always welcoming to long-term sustainable growth stories, especially category defining brands," he said. Schulman also shared his pitch to investors as the company launches it IPO.
Share:
More In Business
How Boeing Can Regain Trust After the 737 Max 9 Disaster
Former Medtronic CEO and author of 'True North' Bill George explains the steps Boeing leadership must take to regain client and consumer trust after 737 Max 9 production was stopped.
Amazon to iRobot: iCannot Buy You
Amazon blamed "regulatory hurdles" for calling off its proposed acquisition of robot vacuum maker iRobot. Not even a Roomba could clean up the deal's antitrust scrutiny.
CEO of FanDuel on Plans for 2024, Super Bowl Excitement, and the 'Taylor Swift Effect'
To celebrate Flutter Entertainment's debut on the NYSE, FanDuel CEO Amy Howe shares her thoughts on the company's plans for growth, the future of online sportsbetting, and Super Bowl Sunday.
Major Tech Earnings Out This Week
Investopedia's Caleb Silver shares thoughts on the upcoming Fed meeting, why individual investors are still slightly skeptical, and what he's looking for from mega cap tech earnings.
Your Taxes Are Due April 15: Here’s Our Plan for Getting Them Done
Season's greetings! Tax season, that is. January 29 is the first day you can file your tax return. We walk you through each step — plus a checklist you can download.
Could a Device Used in Sports Help Reduce Traumatic Brain Injuries?
The Q-Collar helps protect athletes from impact-related concussions. Now, the U.S. Army is evaluating if the device could help reduce traumatic brain injury cased by blast weapons.
These Are the Best and Worst States to Retire in the U.S.
A new retirement report looks at cost of living, tax-friendliness, and access to medical care. Did your state make the list?
Vaxxinity Wants to Bring Accessible Vaccines for Chronic Illness to Market
Co-founder and executive chairman of the board at Vaxxinity Lou Reese shares how the company is working to bring vaccines for chronic illnesses like heart disease and Parkinson’s to market with an eye for accessibility.
Inflation Worries Aren’t Quite Over Yet
Mario Veneroso, Kingsview Asset Management Partner, weighs in on the latest economic data and whether the market is pricing in too many rate cuts for the coming year.
